Status: Closed — this petition is no longer accepting signatures.
Final supporters
Dear Idaho Medicaid P&T Members:
We, the providers in Idaho that diagnose and treat patients who suffer from Opioid Use Disorder (OUD), request that Sublocade be made available as a pharmacy benefit as a preferred agent in combating the Opioid Crisis faces many patients in our great state of Idaho.
Sublocade is a unique formulation of buprenorphine form given as a once-a-month subcutaneous injection. This formulation provides many benefits not found in other formulations of buprenorphine, mainly no misuse, abuse, or diversion. Furthermore, the sustained high plasma concentration of buprenorphine (such as those provided from Sublocade) has additional benefits in reducing the Fentanyl effect, such as respiratory depression. Fentanyl is a highly addictive and dangerous synthetic opioid often mixed (laced) in most illicit opioids.
Patients who struggle with OUD find adherence to oral medications challenging, especially early in the road to recovery. Sublocade is unique because it allows the patients to be completely compliant with our treatment parameters while suppressing the likelihood of continued use (relapse).
Sublocade is far too valuable of a tool in the fight against the Opioid Crisis in Idaho not to allow us, medical providers, as a treatment alternative to our patients.
Thank you for your careful consideration of our request.
Sincerely,
The Medical Providers of Idaho.
More like this
The Faulty, Flawed Decision by the FDA Regarding Probuphine; a Real Setback in…
Legalize Medical Cannabis in the State of Idaho
13 Comments
I would love to bring this to my medicaid patients. There is no risk for diversion with sublocade and it allows for increased safety with patients. It is most definitely a life saving medication. Certain safe and sober housing options don't allow patients to be on PO bupe b/c they don't want a controlled substance kept in house. This wouldn't be an issue with sublocade. Also, this would be advantageous for both drug court and mental health court participants.
As an MAT provider, not having Sublocade available has hurt my patients. There are two that would have benefitted but due to lack of access ended up relapsing.
Additionally, Sublocade is a necessary medication to reduce the dangers and issues caused by NPF and Fentapills that are flooding Idaho.
The NYT today reported 2021 seet a record nationally for overdose death from opioids: 108,000. Subl;ocade is by far the most rational and effective treatment for opioid use disorder. The fact that it is not available to our Medicaid patients is catastrophic. Suboxone is helpful, Sublocade is a game changer. No diversion, tight supervision. Immediate recognition of noncompliance with follow-up. If we are serious about establishing long-term sobriety in this population, the P&T committee will approve the availability of this drug.
This would help so many people
Dead addicts can not get clean! Someone that I knew, died this week from a fentanyl overdose. Scott Watkins MSN, PMHNP-BC, CARN-AP
I support this request for the inclusion of Sublocade as a preferred agent on the Medicaid formulary. As others have noted, the majority of those treated with MAT in Idaho are covered by Medicaid. As a psychiatric provider in a forensic setting, I see many individuals come into custody who are treated with oral MAT agents in the community. These oral agents are usually not continued and that puts the individual at greater risk of relapse when they are released, often in less than 30 days from their arrest.
Share this petition
Share this petition to help it reach more people.
Your share link
Status: Closed — this petition is no longer accepting signatures.
Final supporters
Dear Idaho Medicaid P&T Members:
We, the providers in Idaho that diagnose and treat patients who suffer from Opioid Use Disorder (OUD), request that Sublocade be made available as a pharmacy benefit as a preferred agent in combating the Opioid Crisis faces many patients in our great state of Idaho.
Sublocade is a unique formulation of buprenorphine form given as a once-a-month subcutaneous injection. This formulation provides many benefits not found in other formulations of buprenorphine, mainly no misuse, abuse, or diversion. Furthermore, the sustained high plasma concentration of buprenorphine (such as those provided from Sublocade) has additional benefits in reducing the Fentanyl effect, such as respiratory depression. Fentanyl is a highly addictive and dangerous synthetic opioid often mixed (laced) in most illicit opioids.
Patients who struggle with OUD find adherence to oral medications challenging, especially early in the road to recovery. Sublocade is unique because it allows the patients to be completely compliant with our treatment parameters while suppressing the likelihood of continued use (relapse).
Sublocade is far too valuable of a tool in the fight against the Opioid Crisis in Idaho not to allow us, medical providers, as a treatment alternative to our patients.
Thank you for your careful consideration of our request.
Sincerely,
The Medical Providers of Idaho.
13 Comments
Most of my patients on Sublocade injectable are able to discontinue MAT and continue with only therapy within several months, much easier than with Suboxone films/tablets. Unfortunately, that is only for my private insurance patients. I am hopeful that my MAT patients with Medicaid will have the same benefit. Thank you for considering approval of this petition. Brian Brimhall, PMHNP
I would love to bring this to my medicaid patients. There is no risk for diversion with sublocade and it allows for increased safety with patients. It is most definitely a life saving medication. Certain safe and sober housing options don't allow patients to be on PO bupe b/c they don't want a controlled substance kept in house. This wouldn't be an issue with sublocade. Also, this would be advantageous for both drug court and mental health court participants.
As an MAT provider, not having Sublocade available has hurt my patients. There are two that would have benefitted but due to lack of access ended up relapsing.
Additionally, Sublocade is a necessary medication to reduce the dangers and issues caused by NPF and Fentapills that are flooding Idaho.
The NYT today reported 2021 seet a record nationally for overdose death from opioids: 108,000. Subl;ocade is by far the most rational and effective treatment for opioid use disorder. The fact that it is not available to our Medicaid patients is catastrophic. Suboxone is helpful, Sublocade is a game changer. No diversion, tight supervision. Immediate recognition of noncompliance with follow-up. If we are serious about establishing long-term sobriety in this population, the P&T committee will approve the availability of this drug.
This would help so many people
Dead addicts can not get clean! Someone that I knew, died this week from a fentanyl overdose. Scott Watkins MSN, PMHNP-BC, CARN-AP
I support this request for the inclusion of Sublocade as a preferred agent on the Medicaid formulary. As others have noted, the majority of those treated with MAT in Idaho are covered by Medicaid. As a psychiatric provider in a forensic setting, I see many individuals come into custody who are treated with oral MAT agents in the community. These oral agents are usually not continued and that puts the individual at greater risk of relapse when they are released, often in less than 30 days from their arrest.
Share this petition
Share this petition to help it reach more people.
Your share link
Petitions like this
Other petitions you might want to support
Scan to share
Anyone who scans this can sign the petition.
Most of my patients on Sublocade injectable are able to discontinue MAT and continue with only therapy within several months, much easier than with Suboxone films/tablets. Unfortunately, that is only for my private insurance patients. I am hopeful that my MAT patients with Medicaid will have the same benefit. Thank you for considering approval of this petition. Brian Brimhall, PMHNP